Showing 1 - 20 results of 27 for search 'T. S. Slørdahl', query time: 0.05s
Refine Results
-
1
Teambasert læring – en studentaktiviserende og lærerstyrt undervisningsform by Børge Lillebo, Tobias S. Slørdahl, Ivar Skjåk Nordrum
Published 2017-01-01
Article -
2
Interrater reliability of a national acute myocardial infarction register by Govatsmark RES, Sneeggen S, Karlsaune H, Slørdahl SA, Bønaa KH
Published 2016-08-01
Article -
3
-
4
-
5
-
6
Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? by Anne Marit Sponaas, Anders Waage, Anders Waage, Esten N. Vandsemb, Kristine Misund, Magne Børset, Magne Børset, Anders Sundan, Tobias Schmidt Slørdahl, Tobias Schmidt Slørdahl, Therese Standal, Therese Standal
Published 2021-02-01
Article -
7
-
8
-
9
Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway) by Nilsen Tom IL, Nauman Javaid, Stensvold Dorthe, Wisløff Ulrik, Slørdahl Stig A, Vatten Lars
Published 2011-09-01
Article -
10
-
11
P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Published 2023-08-01
Article -
12
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. by Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy Bremnes, Magne Børset, Lill-Tove Busund, Tobias Slørdahl
Published 2017-01-01
Article -
13
-
14
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias S. Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Published 2024-04-01
Article -
15
-
16
P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY by Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysén, Emil Hermansen, Fredrik Schjesvold
Published 2023-08-01
Article -
17
-
18
-
19
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration by Magnus Aassved Hjort, Håkon Hov, Pegah Abdollahi, Esten Nymoen Vandsemb, Unn-Merete Fagerli, Bendik Lund, Tobias Schmidt Slørdahl, Magne Børset, Torstein Baade Rø
Published 2018-04-01
Article -
20
P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE by T. S. Slørdahl, F. B. Askeland, M. S. S. Hanssen, S. M. Sundt-Hansen, N. T. Vethe, H. Hjorth-Hansen, M. H. Fenstad, A. Waage, Ø. Hjertner, F. Schjesvold, A. Sundan
Published 2022-06-01
Article